Literature DB >> 3582476

Studies on performance with aspirin and paracetamol and with the centrally acting analgesics meptazinol and pentazocine.

C M Bradley, A N Nicholson.   

Abstract

Effects of aspirin (325 and 650 mg) and paracetamol (500 and 1000 mg), and of the centrally acting analgesics meptazinol (100 and 200 mg) and pentazocine (25 and 50 mg) on visuo-motor coordination and dynamic visual acuity, together with critical flicker fusion, digit symbol substitution, complex reaction time and subjective assessments of mood, were studied from 0.75-2.0 h after ingestion by seven healthy female adults. The study was double-blind and placebo controlled, and triprolidine (10 mg) was used as the active control. No effects of meptazinol and paracetamol on performance were observed. Pentazocine (25 mg) impaired performance on digit symbol substitution (p less than 0.05) and aspirin (650 mg) appeared to have shortened complex reaction time (p less than 0.05). Meptazinol (100 mg) increased the component of mood assessments related to wakefulness (p less than 0.05). Impaired performance with pentazocine may involve opioid receptor activity, while the apparent alerting effect of meptazinol may relate to its cholinergic activity. The possible effect of aspirin on reaction time needs to be confirmed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582476     DOI: 10.1007/bf00542185

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  SITE OF ACTION OF NARCOTIC AND NON-NARCOTIC ANALGESICS DETERMINED BY BLOCKING BRADYKININ-EVOKED VISCERAL PAIN.

Authors:  R K LIM; F GUZMAN; D W RODGERS; K GOTO; C BRAUN; G D DICKERSON; R J ENGLE
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-11-01

2.  Flicker fusion frequency; background and applications.

Authors:  E SIMONSON; J BROZEK
Journal:  Physiol Rev       Date:  1952-07       Impact factor: 37.312

3.  Visual motor co-ordination and dynamic visual acuity.

Authors:  R G Borland; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

4.  Determination of receptors that mediate opiate side effects in the mouse.

Authors:  A G Hayes; M B Tyers
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

5.  Current concepts concerning the mode of action of meptazinol as an analgesic.

Authors:  D Green
Journal:  Postgrad Med J       Date:  1983       Impact factor: 2.401

6.  Inhibition of cholinesterases by the opioid analgesic meptazinol.

Authors:  A Galli
Journal:  Biochem Pharmacol       Date:  1985-05-01       Impact factor: 5.858

7.  A double-blind comparison of meptazinol versus paracetamol and placebo in acute and chronic painful conditions presented to the general practitioner.

Authors:  A G Wade; P J Ward
Journal:  Curr Med Res Opin       Date:  1982       Impact factor: 2.580

8.  Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

9.  The H1-antagonist mequitazine: studies on performance and visual function.

Authors:  A N Nicholson; B M Stone
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Effect of meptazinol and ethanol on human psychomotor performance and mood ratings.

Authors:  G Tedeschi; A T Smith; A Richens
Journal:  Hum Toxicol       Date:  1984-02
View more
  9 in total

1.  Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients.

Authors:  Markus B Schumacher; Stefan Jongen; Anja Knoche; Frank Petzke; Eric F Vuurman; Mark Vollrath; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2017-02-12       Impact factor: 4.530

2.  Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

3.  Aspirin: effects on performance in man.

Authors:  C M Bradley; A N Nicholson
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Parenteral pentazocine: effects on psychomotor skills and respiration, and interactions with amitriptyline.

Authors:  U Saarialho-Kere; M J Mattila; T Seppälä
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

6.  The effect of diclofenac and ketoprofen on halothane MAC in rabbit.

Authors:  M G Rorarius; G A Baer; T Metsä-Ketelä
Journal:  Agents Actions       Date:  1993-03

7.  Central effects of the calcium antagonist, nifedipine.

Authors:  D G McDevitt; D Currie; A N Nicholson; N A Wright; M B Zetlein
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

8.  A possible link between sensation-seeking status and positive subjective effects of oxycodone in healthy volunteers.

Authors:  James P Zacny
Journal:  Pharmacol Biochem Behav       Date:  2009-12-31       Impact factor: 3.533

9.  Enhancement of propoxyphene bioavailability by ethanol. Relation to psychomotor and cognitive function in healthy volunteers.

Authors:  C Girre; M Hirschhorn; L Bertaux; S Palombo; F Dellatolas; R Ngo; M Moreno; P E Fournier
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.